BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 23945595)

  • 1. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
    Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
    Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
    Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
    Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for emergency contraception.
    Shen J; Che Y; Showell E; Chen K; Cheng L
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD001324. PubMed ID: 28766313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for emergency contraception.
    Shen J; Che Y; Showell E; Chen K; Cheng L
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD001324. PubMed ID: 30661244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial.
    Wu S; Godfrey EM; Wojdyla D; Dong J; Cong J; Wang C; von Hertzen H
    BJOG; 2010 Sep; 117(10):1205-10. PubMed ID: 20618314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ulipristal acetate for emergency contraception and its effect on the subsequent bleeding pattern when administered before or after ovulation.
    Li HW; Lo SS; Ng EH; Ho PC
    Hum Reprod; 2016 Jun; 31(6):1200-7. PubMed ID: 27052501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency contraception.
    Gemzell-Danielsson K; Rabe T; Cheng L
    Gynecol Endocrinol; 2013 Mar; 29 Suppl 1():1-14. PubMed ID: 23437846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study.
    Envall N; Groes Kofoed N; Kopp-Kallner H
    Acta Obstet Gynecol Scand; 2016 Aug; 95(8):887-93. PubMed ID: 27109900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates.
    Turok DK; Jacobson JC; Dermish AI; Simonsen SE; Gurtcheff S; McFadden M; Murphy PA
    Contraception; 2014 Mar; 89(3):222-8. PubMed ID: 24332433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wider opportunities for IUD insertion.
    Cole LP; Potts DM
    IPPF Med Bull; 1983 Feb; 17(1):2-3. PubMed ID: 12264751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.
    Glasier AF; Cameron ST; Fine PM; Logan SJ; Casale W; Van Horn J; Sogor L; Blithe DL; Scherrer B; Mathe H; Jaspart A; Ulmann A; Gainer E
    Lancet; 2010 Feb; 375(9714):555-62. PubMed ID: 20116841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.
    Ramanadhan S; Goldstuck N; Henderson JT; Che Y; Cleland K; Dodge LE; Edelman A
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013744. PubMed ID: 36847591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
    Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK
    Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day-specific probabilities of conception in fertile cycles resulting in spontaneous pregnancies.
    Stirnemann JJ; Samson A; Bernard JP; Thalabard JC
    Hum Reprod; 2013 Apr; 28(4):1110-6. PubMed ID: 23340057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
    Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE
    Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
    Turok DK; Gero A; Simmons RG; Kaiser JE; Stoddard GJ; Sexsmith CD; Gawron LM; Sanders JN
    N Engl J Med; 2021 Jan; 384(4):335-344. PubMed ID: 33503342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
    Fay KE; Clement AC; Gero A; Kaiser JE; Sanders JN; BakenRa AA; Turok DK
    Contraception; 2021 Nov; 104(5):561-566. PubMed ID: 34166648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.